The design goal of the ClearPoint Maestro® Brain Model is to enable highly accurate ClearPoint interventions under both MRI and CT guidance by facilit...
Pfizer Inc. (NYSE:PFE) announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Supplemental New Drug Applications (sNDAs) fo...
According to the Global Cancer Observatory, in Saudi Arabia there are 830 new kidney cancer cases were registered in 2018, furthermore, 249 people were d...
Agilent Technologies Inc. (NYSE: A) announced the latest addition to the Cary 3500 UV-Vis Series with the release of the Agilent Cary 3500 Flexible U...
Lack of access to qualified health personnel combined with an alarming prevalence of noncommunicable diseases (NCDs) such as cardiometabolic diseases (CMDs...
Ideal for the transportation of life-saving pharmaceutical, biotech and life-science products, Tower’s robust, reliable, reusable solutions are a wel...
The proceeds will be deployed to enable Unibio's vision of feeding the world's growing population in a sustainable way. Unibio will use the funds to roll-o...
The proceeds from this Series A extension round are being utilized to advance the development of Trobix Bio's products and cutting-edge proprietary platfor...
The Middle East is a rapidly growing region, with a population of over 300 million people and a large and growing demand for healthcare services. The regio...
Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and GenoScreen, an innovative genomics company, have launched...
© 2025 Biopharma Boardroom. All Rights Reserved.
